Farhad Naseh, MD Prema Modak, MD
Ghada Orkubi, MD Tamara Mendez, OD
Sara Tavassoli, OD
 
 
Call Today
(301) 840-2208
 
Office Hours:
Monday - Friday: 8:30am - 5pm
Selective Saturdays: 9am - 2pm
 
 
 
Educational Multimedia
Reviews
Make an Appointment
Order Contact Lenses
Evaluate Your Visit
On-line Promotions!
 
Languages We Speak
Arabic, Chinese, Persian, Russian, Spanish, Tagalog, Tamil, French, Creole, Turkish and of course English
 

iStent: Managing your glaucoma while treating cataracts

iStent can be implanted during your cataract surgery procedure. Once implanted, iStent will begin working to safely and effectively manage pressure. What’s more, patients who receive iStent may experience a reduction in glaucoma medications; Dr. Naseh will let you know what is advisable in your case. While a highly innovative technology, how iStent works is elegantly simple:

  • If you have glaucoma, over time the eye’s natural drainage system becomes clogged.
  • iStent creates a permanent opening through the blockage to improve the eye’s natural outflow.
  • Restoring this mechanism lowers and controls pressure within the eye.

iStent is the world's tiniest medical device – 20,000 times smaller than the intraocular lenses (IOL) used in your cataract surgery. But the size of iStent is only part of its story. By increasing the eye’s ability to drain fluid, this technology is designed to reduce the pressure in your eye.

While mild-to-moderate open-angle glaucoma is very common, many people are unaware of their condition, especially in the early stages, when their vision may be unaffected. In many people, open-angle glaucoma is characterized by an increase in the intraocular pressure (IOP) of your eye. This pressure is caused by the buildup of fluid within the eye. Too much fluid raises pressure, which can cause the gradual loss of vision. And while glaucoma moves slowly, its damage is irreparable.

In a U.S. clinical study, 68% of glaucoma patients who received iStent remained medication free at 12 months while sustaining a target IOP of ≤ 21 mm Hg vs. only 50% of patients who underwent cataract surgery alone.

 
 
Maryland Eye Institute 6 Montgomery Village Ave. Suite 103 Gaithersburg, MD 20879 Phone: (301) 840-2208 Fax: (301) 840-2210

© 2018 All content is the property of Maryland Eye Institute ™ & assoc. vendors. | DISCLAIMER | HIPAA | SiteMap
Website Powered and Developed by EyeVertise.com